Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_assertion type Assertion NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_head.
- NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_assertion description "[At 12 months of age, the APPswe/PS1-A246E/hCOX-2 triple-transgenic mice showed an elevation in the number of phosphorylated retinoblastoma (pRb) tumor suppressor protein and active caspase-3 immunopositive neurons, compared to double APPswe/PS1-A246E or single hCOX-2 transgenic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_provenance.
- NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_assertion evidence source_evidence_literature NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_provenance.
- NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_assertion SIO_000772 11959394 NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_provenance.
- NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_assertion wasDerivedFrom befree-2016 NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_provenance.
- NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_assertion wasGeneratedBy ECO_0000203 NP352216.RAAD3IhI-GR_OZPFs3chUOuX9xK6aO67BlveFPGb_bYgU130_provenance.